Salvia Sanjay Jain MD

Hematologic Oncology

Physician

55 Fruit StBoston, MA 02114
Phone+1 650-224-0183

Dr. Jain is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jain's full profile Already have an account?

Education & Training

NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012
Tufts Medical CenterResidency, Internal Medicine, 2006 - 2009
Mahatma Gandhi Memorial Medical CollegeClass of 2004

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2012 - Present
MA State Medical License 2013 - 2027
NY State Medical License 2009 - 2012
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Online Medical Record, Beth Israel Deaconess Medical Center, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification Online Medical Record, Beth Israel Deaconess Medical Center, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification Quality Data Center, Massachusetts eHealth Collaborative (MAeHC), 2014, 2016-2017

Publications & Presentations

PubMed

Outcomes in early stage peripheral T-cell lymphoma by stage, histology, and treatment patterns.
Robert Stuver, Zachary R Moore, Stefan K Barta, Rahul S Bhansali, Ruth Choa
Haematologica. 2026-06-11
Allogeneic transplant outcomes in T-cell prolymphocytic leukemia: a single-center retrospective study.
Mwanasha Merrill, Haesook T Kim, Amar H Kelkar, Kevin Panaro, Rakuyo Tamada
Leukemia & Lymphoma. 2026-06-01
Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium.
Colin J Thomas, Min Jung Koh, Omar Elghawy, Jessy Xinyi Han, Leora Boussi
Leukemia & Lymphoma. 2026-05-01

Abstracts/Posters

Development of Novel Second Generation DC/Tumor Fusion Vaccine in Lymphoma
Salvia Jain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

A Novel Monoclonal Antibody Combination Plus DC/AML Fusion Vaccine Eradicates AML in an Immunocompetent Murine Model
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

An International Research Effort Led by Mass General Brigham Is Pioneering Breakthroughs in Rare Blood CancersDecember 17th, 2025
New Drug Combo Safe, Effective for T-cell Lymphoma: What to KnowJuly 21st, 2025
Novel Drug Combination Shows Promise in Treating T-cell LymphomaJuly 1st, 2025